Brickell Biotech, Inc.
Pagina dedicata companiei Brickell Biotech, Inc. listata cu simbolul US.BBI
Descriere companie[edit | ]
Brickell Biotech, Inc. (www.brickellbio.com) is a clinical-stage pharmaceutical company. The Company focuses on the development of therapeutics for the treatment of skin diseases. The Company's Phase III clinical-stage investigational product candidate, sofpironium bromide, is a chemical entity that belongs to a class of medications called anticholinergics is for the treatment of primary axillary (underarm) hyperhidrosis. The Company is also conducting early research programs targeting various skin diseases.
Grafic actiuni companie[edit | ]